Association of Sex With Outcomes in Patients Undergoing Percutaneous Coronary Intervention
Bleeding after percutaneous coronary intervention (PCI) was more common in women, but the effect of two antiplatelet strategies on death ...
Tag: Ticagrelor
Ticagrelor alone non-inferior after one month post drug eluting stent placement
1. In this pre-specified ancillary study of a randomized control trial, ticagrelor alone after one month was found non-inferior, but ...
#VisualAbstract: Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers
1. A monoclonal antibody fragment to ticagrelor, PB2452, increased platelet function significantly in healthy patients given the oral P2Y12 inhibitor ticagrelor. ...
Ticagrelor reversal agent provides immediate and sustained effect
1. A monoclonal antibody fragment to ticagrelor, PB2452, increased platelet function significantly in healthy patients given the oral P2Y12 inhibitor ...
#VisualAbstract: Effect of Medication Co-payment Vouchers on P2Y12 Inhibitor Use and Major Adverse Cardiovascular Events Among Patients With Myocardial Infarction The ARTEMIS Randomized Clinical Trial
1. In this randomized controlled trial, medication vouchers were associated with a small increase in patient-reported persistence with P2Y12 inhibitors for ...
Medication co-payment vouchers for P2Y12 inhibitors not associated with reduced major adverse cardiovascular events
1. In this randomized controlled trial, medication vouchers were associated with a small increase in patient-reported persistence with P2Y12 inhibitors ...
Ticagrelor and clopidogrel have similar major bleeding rates following thrombolytic therapy
1. Use of ticagrelor resulted in similar rates of major bleeding compared to clopidogrel in patients with ST elevation myocardial ...
The PLATO trial: Ticagrelor vs clopidogrel for ACS [Classics Series]
1. Treatment with ticagrelor significantly reduces mortality in patients with acute coronary syndrome when compared to clopidogrel. 2. Ticagrelor does ...
